All Type of News
Relocation of KFDA starts this week
From November 4, five health-related government agencies - the Korea Food and Drug Administration, the Korea Centers for Disease Control and Prevention, the National Institute of Toxicological Research, the Korea Heal...
Medipost to conduct first clinical trial of stem cell therapy
Medipost Co., Ltd., one of the nation’s leading bioengineering firms, said on November 2 that it will conduct its Phase I clinical trial of Neurostem, a placenta based embryonic stem cell, for treatment of Alzheimer’s...
54 substances should be contraindicated, KFDA says
The Korea Food and Drug Administration announced on November 2 that it designated a total of 54 ingredients that cannot co-administered with others during doctor’s prescription or that has safety problems and age limi...
KT&G looks to future with new growth engines
KT&G, Korea’s foremost tobacco group, is busy looking for new growth engines that would empower it over the next decade.
According to KT&G officials, its affiliated company Korea Ginseng Corporation (KGC) has recen...
KFDA warns use of psychotropic weight-loss drug
The Korea Food and Drug Administration has, through its web site (www.kfda.go.kr), issued a guideline to provide brief information on psychotropic weight-loss drugs, the manner by which they take their effects, precau...
Boehringer Kore, Yuhan to co-market Twinsta
Boehringer Ingelheim Korea and Yuhan Corp. will jointly promote Twinsta, a combination drug of telmisartan and amlodipine, from November 1 here.
Twinsta is effective and well tolerated in a range of more complex, d...
Drugmakers call for more clarification of DMF system
Local pharmaceutical firms called for the need to let them understand DMF (drug master file) regulations, saying more frequent information sessions should be held by the Korea Drug Administration.
Starting from nex...
KMA to conduct survey on separation of drug dispensing from medical practice
The Korean Medical Association (KMA) plans to conduct a survey of its members over the current system of separating drug dispensing from medical practice, with an aim to improve the system.
However, sources say the...
Janssen Korea starts selling anti-AIDS drug
Janssen Korea said on November 1 it has started selling its anti-AIDS drug Prezista here after being listed in the national health insurance.
Prezistar is a second-generation protease inhibitor (PIs), designed spec...
Who will throne as top drug company?
The local pharmaceutical industry is closely watching which company will gain the number 1 ranking in terms of revenue as Dong-A Pharmaceutical struggles this year against Green Cross which succeeded in overtaking the...
